Patients Professionals Professional oportunities About Novo Nordisk Contact Spain Novo Nordisk Spain / Patients Patients Diabetes Haemostasis Growth hormone Obesity Novo Nordisk in Spain Novo Nordisk is the world leader in the treatment of diabetes. It offers the most complete range of diabetes products in the pharmaceutical industry, including the most advanced insulin delivery systems preferred by patients and healthcare professionals. In addition, Novo Nordisk stands in a prominent position in other therapeutic areas, such as hemostasis, growth hormone, and now also in obesity. Novo Nordisk produces and markets products and services aimed at improving the quality of life of patients, healthcare professionals and society in general. Novo Nordisk does not market its products outside the legal channels for the distribution of medicines in Spain. Products purchased outside of this circuit could be counterfeits and could therefore be a risk to your health Diabetes Diabetes is a chronic disease characterized by the presence of high levels of glucose in the blood. Read more Obesity Obesity is a chronic, complex and multifactorial disease, in which physiological, psychological, environmental, socioeconomic and genetic factors intervene. Read more Haemostasis Hemophilia is a congenital or acquired bleeding disorder caused by a deficiency of factor VIII coagulation (hemophilia A) or factor IX (hemophilia B). Read more Growth hormone Novo Nordisk is one of the world's leading manufacturers of biosynthetic growth hormone. Read more About us Headquartered in Denmark, Novo Nordisk is a global healthcare company and over 90 years of innovation and leadership in diabetes. The company also holds leadership positions in the care of hemophilia and growth disorders. Novo Nordisk employs approximately 42,000 people in 77 countries, and markets its products in more than 165 countries. Novo Nordisk websites NovoNordisk.com Or select: Other countries Other places Novo Nordisk in the world Map, directions and route information © 2017 Copyright Novo Nordisk Pharma, SA Legal Notice